MetaCap

Canton Strategic Earnings

NASDAQ: CNTNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.02-0.09 (-4.27%)

At close: Oct 13, 4:00 PM ET · Delayed 15 min

Pre-market: 2.10 +3.96%

Next earnings date

Wed, Nov 11, 2026

Fiscal period

Sep/2026

Canton Strategic earnings summary

Canton Strategic is scheduled to report Sep/2026 earnings on Nov 11, 2026. In its most recent report on Aug 14, 2026 (Q2 2026), CNTN posted EPS of $-0.08. Revenue for the quarter was $1.5 million.

Across the last 16 reports, CNTN shares moved an average of 23.7% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.

Summary generated from market data by MetaCap's automated system. Methodology

CNTN earnings history

Canton Strategic reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 14, 2026—$-0.08—+8.4%
May 13, 2026—$-0.23—-2.8%
Mar 31, 2026—$0.85—-8.4%
Nov 12, 2025—$-0.34—-15.8%
Aug 14, 2025—$-0.64—+249.6%
May 12, 2025—$-0.99—+2.1%
Mar 26, 2025—$-1.99—-16.7%
Nov 7, 2024—$-2.45—-8.4%
Aug 9, 2024—$-2.42—+0.9%
May 9, 2024—$-2.55—-4.0%
Feb 23, 2024—$-9.70—+5.9%
Nov 7, 2023—$-39.42—+11.7%
Aug 11, 2023—$-52.06—-23.7%
May 22, 2023—$-5.84—-10.1%
Mar 16, 2023—$-18.40—+4.0%
Nov 14, 2022—$-0.18—-6.1%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related